Metabolic & Cardiometabolic
Part of Biotech - Drug Development
 LLY | Eli Lilly & Co. | $1.0t | $1160.89 | +1.3% | 1.6M |
 AZN | AstraZeneca PLC | $243.3b | $158.59 | +1.3% | 1.8M |
 MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | $11.5b | $496.85 | +0.5% | 272.3K |
 PTGX | Protagonist Therapeutics, Inc | $9.1b | $138.71 | -1.4% | 470.5K |
 TERN | Terns Pharmaceuticals, Inc. Common Stock | $6.1b | $52.97 | +0.0% | 2.3M |
 KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $5.9b | $78.68 | +1.0% | 319.8K |
 TVTX | Travere Therapeutics, Inc. Common Stock | $5.4b | $56.96 | -2.9% | 1.6M |
 VKTX | Viking Therapeutics, Inc | $3.8b | $28.54 | -3.1% | 6.7M |
 MBX | MBX Biosciences, Inc. Common Stock | $2.8b | $56.88 | -3.0% | 298.8K |
 NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $2.8b | $21.95 | -2.3% | 1.1M |
 MLYS | Mineralys Therapeutics, Inc. Common Stock | $2.1b | $23.25 | -5.8% | 1.1M |
 SEPN | Septerna, Inc. Common Stock | $1.8b | $35.72 | -5.7% | 432.4K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.5b | $26.46 | -0.1% | 531.9K |
 MNKD | Mannkind Corporation | $1.2b | $3.75 | -2.7% | 2.1M |
 ESPR | Esperion Therapeutics, Inc. | $0.8b | $3.19 | 0.0% | N/A |
 LXRX | Lexicon Pharmaceuticals, Inc. | $0.8b | $1.76 | +0.6% | 1.4M |
 GYRE | Gyre Therapeutics, Inc. Common Stock | $0.8b | $7.07 | -3.8% | 113.1K |
 SGMT | Sagimet Biosciences Inc. Series A Common Stock | $0.6b | $8.76 | -3.0% | 778.8K |
 ALT | Altimmune, Inc. Common Stock | $0.5b | $2.68 | +0.4% | 2.2M |
 RZLT | Rezolute, Inc. Common Stock (NV) | $387.9m | $4.32 | 0.0% | 2.1M |
 BIOA | BioAge Labs, Inc. Common Stock | $303.4m | $6.29 | -1.1% | 3.1M |
 ORMP | Oramed Pharmaceuticals Inc. | $186.8m | $4.42 | -3.7% | 80.5K |
 CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $171.3m | $1.31 | +0.4% | 4.5M |
 VTVT | vTv Therapeutics Inc. Class A Common Stock | $120.9m | $29.96 | 0.0% | 26.8K |
 VANI | Vivani Medical, Inc. Common Stock (DE) | $111.0m | $1.25 | +0.8% | 99.4K |
 AARD | Aardvark Therapeutics, Inc. Common Stock | $109.2m | $5.01 | -4.2% | 245.3K |
 MIST | Milestone Pharmaceuticals Inc. Common Shares | $100.8m | $0.77 | -2.0% | 1.4M |
 BMEA | Biomea Fusion, Inc. Common Stock | $92.1m | $1.25 | -3.8% | 669.0K |
 TENX | Tenax Therapeutics, Inc. | $74.1m | $1.94 | -1.5% | 1.1M |
 GUTS | Fractyl Health, Inc. Common Stock | $64.7m | $4.58 | +0.3% | 148.0K |
 VERU | Veru Inc. | $42.8m | $2.52 | -2.5% | 1.5M |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $34.6m | $5.38 | 0.0% | 12.3K |
 GRDX | GridAI Technologies Corp. Common Stock | $27.2m | $4.22 | +7.8% | 101.4K |
 LPCN | Lipocine Inc. | $16.9m | $2.10 | +0.5% | 12.2K |
 NCEL | NewcelX Ltd. Ordinary Shares | $16.5m | $3.04 | 0.0% | 7.2K |
 MTVA | MetaVia Inc. Common Stock | $10.1m | $1.50 | -2.6% | 85.8K |
 SKYE | Skye Bioscience, Inc. Common Stock | $7.4m | $1.66 | -0.9% | 30.6K |
 CURX | Curanex Pharmaceuticals Inc Common Stock | $7.4m | $4.88 | 0.0% | 42.3K |
 GLMD | Galmed Pharmaceuticals Ltd. | $4.3m | $4.59 | 0.0% | N/A |
 CVKD | Cadrenal Therapeutics, Inc. Common Stock | $3.4m | $0.99 | +8.9% | 94.3K |
 ELAB | PMGC Holdings Inc. Common Stock | $2.7m | $3.27 | 0.0% | 14.0K |
 TCRT | Alaunos Therapeutics, Inc. Common Stock | $2.1m | $0.75 | -7.1% | 121.0K |